Park Ha Biological Technology Co., Ltd. (BYAH)

Revenue by Segment

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
Products Sales	1.01M	707.23K	648.75K	981.84K	876.75K
Franchise Fees	1.51M	1.67M	1.81M	937.55K	-
Other	-	-	-	-	54.28K
Total	2.52M	2.38M	2.46M	1.92M	931.04K

Revenue by Geography

Financials in millions USD. Fiscal year is November - October.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct 31, 2025	Oct 31, 2024	Oct 31, 2023	Oct 31, 2022	Oct 31, 2021
People’S Republic of China	2.52M	2.38M	2.46M	1.92M	931.04K
Total	2.52M	2.38M	2.46M	1.92M	931.04K

Data Source: S&P Global Market Intelligence Last updated: Jul 24, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 27, 2026

Data Sources Report a data error